Resources

This fact sheet provides information on the national NBS decision-making pathway, including the role of each committee in the process.

This fact sheet provides information about what NBS expansion means for families and consumers, expansion progress to date, and upcoming milestones.

This publication outlines the key findings of the national readiness assessment conducted in 2023. The aim of the readiness assessment is to understand how NBS programs operate nationally. It also looks at critical factors for achieving consistency and expanding the number of conditions screened.

This document outlines the governance of the Jurisdictional Haemopoietic Progenitor Cell Committee (JHPCC). This committee supports the implementation of the National HPC Framework. It advises Health Chief Executives and Health Ministers on haemopoietic progenitor cell (HPC) policy and funding.

This publication outlines the key findings from our public consultation on the expansion of newborn bloodspot screening programs.

This report gives an overview of the public consultation process that we undertook for the expansion of newborn bloodspot screening programs.

Tasmanian Health Service information brochure explaining how newborn bloodspot screening works in Tasmania.

South Australia Pathology brochure explaining how newborn bloodspot screening works in South Australia.

The BMTP helps patients access international haemopoietic progenitor cell (HPC) donors for transplants. This publication guides people on applying for, participating in and administering the BMTP.

The BMTP helps patients access international haemopoietic progenitor cell (HPC) donors for transplants. Use this form to apply for funding under the BMTP.

The Newborn Bloodspot Screening National Policy Framework guides the national policies needed to support the ongoing success of newborn bloodspot screening in Australia.